Evidence map›Paper›PMID 34574191›Full record

ArticleFoods (Basel, Switzerland)2021

Bo Yang, Fuli Zheng, Catherine Stanton, Reynolds Paul Ross, Jianxin Zhao, Hao Zhang, Wei Chen

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Foods (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. The role of probiotics in adolescents' obesity.Frontiers in cellular and infection microbiology · 2025
    Review
  10. Frontiers in nutrition · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Remodeling of the gut microbiome byFrontiers in microbiology · 2023
    Article
  17. Role of microencapsulatedFrontiers in microbiology · 2023
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Bo YangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.ORCID 0000-0002-1347-3718
Fuli ZhengState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Catherine StantonInternational Joint Research Laboratory for Pharmabiotics & Antibiotic Resistance, Jiangnan University, Wuxi 214122, China.ORCID 0000-0002-6724-7011
Reynolds Paul RossInternational Joint Research Laboratory for Pharmabiotics & Antibiotic Resistance, Jiangnan University, Wuxi 214122, China.ORCID 0000-0003-4876-8839
Jianxin ZhaoState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Hao ZhangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.ORCID 0000-0002-9192-4684
Wei ChenState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Jiangnan University · CN

Funding

111 project BP0719028Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province Not ApplicableFundamental Research Funds for the Central Universities JUSRP52003BNational First-Class Discipline Program of Food Science and Technology JUFSTR20180102National Natural Science Foundation of China Nos. 32021005, 31820103010
6 · The paper itself

Abstract

Metabolic syndrome is caused by an excessive energy intake in a long-term, high-fat and/or high-sugar diet, resulting in obesity and a series of related complications, which has become a global health concern. Probiotics intervention can regulate the gut microbiota and relieve the systemic and chronic low-grade inflammation, which is an alternative to relieving metabolic syndrome. The aim of this work was to explore the alleviation of two different

Indexed as

gut microbiotaLactobacillus reuterimetabolic syndrome

Identifiers

PMID34574191
PMCPMC8469823
OpenAlexW3197026402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.